Agency Forms Undergoing Paperwork Reduction Act Review
Federal RegisterFeb 22, 2019
Ask Donna
What actually matters in this document.
Text
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-0978]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Emerging Infections Program to the Office of Management and Budget (OMB) for review and approval. CDC previously published a “Proposed Data Collection Submitted for Public Comment and Recommendations” notice on November 15, 2018 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that:
(a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to be collected;
(d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology,
e.g.,
permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to
omb@cdc.gov.
Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication.
Proposed Project
Emerging Infections Program (OMB Control No. 0920-0978, Expiration Date 5/31/2021)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.
Activities of the EIPs fall into the following general categories: (1) Active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) Address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.
A revision is being submitted to make existing collection instruments clearer and to add several new forms specifically surveying laboratory practices. These forms will allow the EIP to better detect, identify, track changes in laboratory testing methodology, gather information about laboratory utilization in the EIP catchment area to ensure that all cases are being captured, and survey EIP staff to evaluate program quality.
The total estimated burden is 40,601 hours per year, an increase of 612 hours. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
Type of respondent
Form name
Number of
responders
Number of
responses per
respondent
Average
burden per
response
(in hours)
State Health Department
ABCs Case Report Form
10
809
20/60
ABCs Invasive Pneumococcal Disease in Children Case Report Form
10
22
10/60
ABCs
H. influenzae
Neonatal Sepsis Expanded Surveillance Form
10
6
10/60
ABCs Severe GAS Infection Supplemental Form
10
136
20/60
ABCs Neonatal Infection Expanded Tracking Form
10
37
20/60
FoodNet Campylobacter
10
942
21/60
FoodNet Cyclospora
10
163
10/60
FoodNet Listeria monocytogenes
10
15
20/60
FoodNet Salmonella
10
789
21/60
FoodNet Shiga toxin producing E. coli
10
205
20/60
FoodNet Shigella
10
213
10/60
FoodNet Vibrio
10
34
10/60
FoodNet Yersinia
10
48
10/60
FoodNet Hemolytic Uremic Syndrome Case Report Form
10
10
1
FoodNet Clinical Laboratory Practices and Testing Volume—NEW
10
70
20/60
Influenza Hospitalization Surveillance Network Case Report Form
10
1000
25/60
Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English/Spanish)
10
333
5/60
Influenza Hospitalization Surveillance Project Vaccination Phone Script (English/Spanish)
10
333
5/60
Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)
10
333
5/60
FluSurv-NET Laboratory Survey—NEW
10
23
10/60
HAIC CDI Case Report Form
10
1650
35/60
HAIC CDI Annual Laboratory Survey—NEW
10
16
10/60
HAIC CDI Annual Surveillance Officers Survey—NEW
10
1
15/60
HAIC CDI LTCF Survey—NEW
10
45
5/60
HAIC Multi-site Gram-Negative Bacilli Case Report Form
(MuGSI-CRE/CRAB)
10
500
25/60
HAIC Multi-site Gram-Negative Surveillance Initiative—Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL)
10
1200
25/60
HAIC Invasive Methicillin-resistant
Staphylococcus aureus
(MRSA)
10
474
25/60
HAIC Invasive Methicillin-sensitive
Staphylococcus aureus
(MSSA)
10
754
25/60
HAIC Invasive
Staphylococcus aureus
Annual Laboratory Survey—NEW
10
11
8/60
HAIC Invasive
Staphylococcus aureus
Annual Surveillance Officers Survey—NEW
10
1
10/60
HAIC Candidemia Case Report Form
9
800
20/60
HAIC Candidemia Periodic Laboratory Survey—NEW
9
15
20/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.
[FR Doc. 2019-03101 Filed 2-21-19; 8:45 am]
BILLING CODE 4163-18-P
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.